| Antisecretory Factor Glioblastoma Phase 2 (NCT05669820) | Peter Siesjö | 2024-01-15 |
| A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation (NCT06005974) | Recursion Pharmaceuticals Inc. | 2024-01-15 |
| Aspirin Resistance in Trinidad. (NCT06228820) | The University of The West Indies | 2024-01-15 |
| The Impact of Nitrous Oxide Sedation on Dental Fear and Anxiety Scores in Children Aged 6-10 Years (NCT07384988) | Shaoxing Maternity and Child Health Care Hospital | 2024-01-15 |
| Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder (NCT05558358) | University of Colorado, Denver | 2024-01-15 |
| A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD). (NCT05919680) | NorthSea Therapeutics B.V. | 2024-01-15 |
| Low-dose Naltrexone for Post-COVID Fatigue Syndrome (NCT05430152) | Luis Nacul | 2024-01-15 |
| Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile Dysfunction (NCT07761806) | Ain Shams University | 2024-01-15 |
| A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients (NCT06703268) | Haisco Pharmaceutical Group Co., Ltd. | 2024-01-15 |
| Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD) (NCT06133101) | Marialena Mouzaki | 2024-01-15 |
| A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants (NCT06213506) | GlaxoSmithKline | 2024-01-15 |
| WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases (NCT06243003) | Fudan University | 2024-01-15 |
| A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT06035393) | Jiangsu HengRui Medicine Co., Ltd. | 2024-01-15 |
| CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors (NCT06503094) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-01-14 |
| A Clinical Study of JS005 in Patients With Ankylosing Spondylitis (NCT06250062) | Shanghai Junshi Bioscience Co., Ltd. | 2024-01-13 |
| Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer：A Prospective, Single-Arm, Phase II Study (NCT07085182) | Zibo Municipal Hospital | 2024-01-13 |
| Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia (NCT06022003) | French Innovative Leukemia Organisation | 2024-01-13 |
| A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus (NCT06106893) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-01-12 |
| Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer (NCT06109467) | H. Lee Moffitt Cancer Center and Research Institute | 2024-01-12 |
| Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma (NCT06907602) | Peking Union Medical College Hospital | 2024-01-12 |
| Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants (NCT06206564) | Frantz Viral Therapeutics, LLC | 2024-01-12 |
| 129Xe MRI Cardiopulmonary (NCT06038630) | Bastiaan Driehuys | 2024-01-12 |
| Effect of High Dose Intravenous Vitamin C in Severe Pneumonia (NCT05842382) | Clinical Research Centre, Malaysia | 2024-01-12 |
| Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial (NCT05773274) | National Cancer Institute (NCI) | 2024-01-12 |
| LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT06479759) | Shanghai Pulmonary Hospital, Shanghai, China | 2024-01-12 |
| A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer (NCT06155396) | RemeGen Co., Ltd. | 2024-01-11 |
| Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain (NCT06077422) | Rutgers, The State University of New Jersey | 2024-01-11 |
| Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy. (NCT05923086) | Orexa BV | 2024-01-11 |
| Comparative Study of USG Guided ESPB vs USG Guided PVB For Post-op Analgesia In Patient's After Open Renal Surgeries (NCT06728514) | Sahiwal medical college sahiwal | 2024-01-11 |
| Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer (NCT06149130) | Tongji Hospital | 2024-01-11 |
| A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer (NCT06218667) | Memorial Sloan Kettering Cancer Center | 2024-01-11 |
| A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) (NCT06109272) | AbbVie | 2024-01-11 |
| Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery (NCT06164743) | VivaVision Biotech, Inc | 2024-01-11 |
| The Effects of Lemborexant on the Ability to Sleep During Daytime (NCT06231641) | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 2024-01-11 |
| Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia. (NCT06270199) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2024-01-11 |
| A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma (NCT06223646) | Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | 2024-01-11 |
| Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD) (NCT05892432) | University of Colorado, Denver | 2024-01-11 |
| A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors (NCT06208410) | Risen (Suzhou) Pharma Tech Co., Ltd. | 2024-01-11 |
| A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors (NCT06214143) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-01-11 |
| Oxytocin Plus Self-compassion Training in Borderline Personality Disorder (NCT07551882) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2024-01-10 |
| Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor (NCT06154226) | The University of Texas Health Science Center, Houston | 2024-01-10 |
| A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors (NCT06257758) | Valerio Therapeutics | 2024-01-10 |
| Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease (NCT05861453) | Afimmune | 2024-01-10 |
| TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C) (NCT06125522) | Pfizer | 2024-01-10 |
| Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer (NCT06027268) | Wake Forest University Health Sciences | 2024-01-10 |
| mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer (NCT06149689) | Fudan University | 2024-01-10 |
| Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers (NCT06840119) | Immunocore Ltd | 2024-01-10 |
| Periodontal Regeneration With Recombinant Human Platelet Derived Growth Factor (rH-PDGF-BB) and Allograft (NCT06162832) | Universidad Autonoma de Nuevo Leon | 2024-01-10 |
| A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) (NCT06256328) | Ono Pharmaceutical Co., Ltd. | 2024-01-10 |
| PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition (NCT05664477) | Roberta Brinton | 2024-01-10 |
| First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer (NCT06375707) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-09 |
| Toripalimab for High-risk Locally Advanced Cervical Cancer (NCT06416696) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-01-09 |
| A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma (NCT05926492) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-01-09 |
| PD-1 Inhibitors Maintenance for cHL Post-autoHCT (NCT06812858) | St. Petersburg State Pavlov Medical University | 2024-01-09 |
| Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression (NCT06263660) | Laureate Institute for Brain Research, Inc. | 2024-01-09 |
| Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB (NCT06114628) | University College, London | 2024-01-09 |
| A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment (NCT06105632) | Pfizer | 2024-01-09 |
| Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis (NCT06329492) | Mayo Clinic | 2024-01-09 |
| Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema (NCT06116916) | Kyowa Kirin Co., Ltd. | 2024-01-09 |
| Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa (NCT07230223) | Isfahan University of Medical Sciences | 2024-01-09 |
| Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy (NCT05927142) | Joachim Aerts, MD PhD | 2024-01-09 |
| SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes (NCT06149793) | University of Minnesota | 2024-01-08 |
| Arginine Replacement Therapy in COVID-19 (NCT05855330) | Emory University | 2024-01-08 |
| Pregnenolone for the Treatment of Alcohol Use Disorder (NCT05781009) | Yale University | 2024-01-08 |
| DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs (NCT06176261) | Nancy Lin, MD | 2024-01-08 |
| POHCA Resuscitation: Evaluation of IM Epinephrine (NCT05166343) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2024-01-08 |
| A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients (NCT06028932) | Yale University | 2024-01-08 |
| Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus (NCT06036004) | University Hospital, Basel, Switzerland | 2024-01-08 |
| Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE) (NCT05486481) | Alfred Chung, MD | 2024-01-08 |
| A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia (NCT05761171) | Children's Oncology Group | 2024-01-08 |
| A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma (NCT06043323) | M.D. Anderson Cancer Center | 2024-01-08 |
| PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL) (NCT04754061) | Ottawa Hospital Research Institute | 2024-01-08 |
| Anti-viral T-cell Therapy by Gamma Capture (NCT06027879) | Paul Szabolcs | 2024-01-08 |
| Endotypic Traits and Obstructive Sleep Apnea Surgery (NCT05953610) | University of California, Los Angeles | 2024-01-07 |
| JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency (NCT06662188) | Jaguar Gene Therapy, LLC | 2024-01-07 |
| Nucleo CMP and Neurorubine Versus Carbamazepine for Classical Trigeminal Neuralgia (NCT07304453) | Karbala University | 2024-01-07 |
| A Prospective Single Arm Phase II Exploratory Study on the Combination of Whole Brain Radiotherapy, Thiotepa Intrathecal Injection and Systemic Treatment of Primary Diseases in the Treatment of Solid Tumor Leptomeningeal Metastasis (NCT06376292) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-01-06 |
| Effects of Probiotic Consumption in Children With Autism Spectrum Disorder (ASD) (NCT06568588) | Universidad San Francisco de Quito | 2024-01-06 |
| Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML (NCT06191263) | Ryvu Therapeutics SA | 2024-01-05 |
| Immediate Effects of High-intensity Laser Therapy on Knee Joint Position Sense and Knee Muscle Strength in Patients with Knee Osteoarthritis (NCT06632119) | Mahidol University | 2024-01-05 |
| Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma (NCT06053658) | M.D. Anderson Cancer Center | 2024-01-05 |
| Phototherapy for Non-responders to Oral Appliance Therapy for Obstructive Sleep Apnea (NCT06960200) | University of Alberta | 2024-01-05 |
| Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer (NCT05754801) | Chinese University of Hong Kong | 2024-01-05 |
| Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma (NCT06045247) | M.D. Anderson Cancer Center | 2024-01-05 |
| Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD (NCT05268796) | Stanford University | 2024-01-05 |
| Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial (NCT06091332) | Huashan Hospital | 2024-01-05 |
| Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant (NCT05820763) | Washington University School of Medicine | 2024-01-05 |
| To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) . (NCT06168383) | Haisco Pharmaceutical Group Co., Ltd. | 2024-01-05 |
| Topical Statin Eye Drop in the Management of the Dry Eye (NCT06208384) | Shahid Beheshti University of Medical Sciences | 2024-01-04 |
| PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717 (NCT06153966) | Ionis Pharmaceuticals, Inc. | 2024-01-04 |
| Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis (NCT06109818) | Beijing InnoCare Pharma Tech Co., Ltd. | 2024-01-04 |
| Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment (NCT05859334) | National Cancer Institute (NCI) | 2024-01-04 |
| Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy (NCT06005610) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-01-04 |
| Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043) (NCT05115838) | Merck Sharp & Dohme LLC | 2024-01-04 |
| Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia (NCT05928390) | RECORDATI GROUP | 2024-01-04 |
| Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (NCT05910801) | Academic and Community Cancer Research United | 2024-01-04 |
| Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma (NCT05847569) | Mayo Clinic | 2024-01-04 |
| Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer (NCT06056804) | Beijing Friendship Hospital | 2024-01-03 |
| A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC (NCT05849298) | Novartis Pharmaceuticals | 2024-01-03 |
| A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly (NCT06082843) | Boehringer Ingelheim | 2024-01-03 |